New generic IM DMPA available for procurement
Mylan Laboratories Limited has received a risk category 1 ranking from the WHO Expert Review Panel for its generic injectable, medroxyprogesterone acetate depot 150mg/ml.
Read More Generic implant receives positive ERP result
folder_open Family Planning
The first generic two-rod sub-dermal levonorgestrel 75mg implant product has received a positive result from the Expert Review Panel (ERP), making it the first of its kind to reach the quality standard for international procurement.
Read More The topmost drug technical advisory body of the Union Health Ministry in India has recommended the introduction of the injectable contraceptive DMPA
folder_open Family Planning
Concept Foundation is pleased to announce that India’s Drugs Technical Advisory Board recently agreed to the introduction of Depot-medroxyprogesterone acetate, or DMPA, under the National Family Planning Programme.
Read More BMGF grant
folder_open Family Planning
The Bill & Melinda Gates Foundation awards Concept Foundation with a grant to continue and expand upon work initiated under QuRHM for DMPA.
Read More